Mondira Bhattacharya

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Debra Benator, Mondira Bhattacharya, Lorna Bozeman et al. · The Lancet · 2002 · 408 citations

Pulmonary Tuberculosis, Treatment And Prevention, Medicine +7

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 316 citations · Full text

Pioglitazone and Heart Failure: Results From a Controlled Study in Patients With Type 2 Diabetes Mellitus and Systolic Dysfunction

Thomas D. Giles, Alan B. Miller, Uri Elkayam et al. · Journal of Cardiac Failure · 2008 · 92 citations

Metabolic Syndrome, Hypertension, Heart Failure +9

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

Charles M. Gerrits, Mondira Bhattacharya, Shivaji Manthena et al. · Pharmacoepidemiology and Drug Safety · 2007 · 81 citations